John S. Yu - 08 Oct 2025 Form 4 Insider Report for Kairos Pharma, LTD. (KAPA)

Role
CEO and Chairman, Director, 10%+ Owner
Signature
/s/ John S Yu
Issuer symbol
KAPA
Transactions as of
08 Oct 2025
Transactions value $
$0
Form type
4
Filing time
26 Nov 2025, 17:24:11 UTC
Previous filing
24 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Yu John S CEO and Chairman, Director, 10%+ Owner C/O KAIROS PHARMA, LTD., 2355 WESTWOOD BLVD, #139, LOS ANGELES /s/ John S Yu 26 Nov 2025 0001550545

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KAPA COMMON STOCK Award $0 +191K +486.03% $0.00 230K 08 Oct 2025 Direct F1, F2
holding KAPA COMMON STOCK 5.32M 08 Oct 2025 By Self as Trustee for The Yu Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 190,840 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 190,840 RSUs are scheduled to vest in full on the first anniversary of the grant date.
F2 Consists of (1) 34,599 shares of common stock (2) 195,506 RSUs which remain subject to vesting.